CYCN Cyclerion Therapeutics, Inc. - Common Stock
$4,12
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 4, 2026
Rango 52S
$1–$8
42% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
$8
+94% upside
P/E (TTM)
-1.1
ROE
—
Margen de Beneficio Neto
—
CYCN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.12
Capitalización Bursátil
—
P/E (TTM)
-1.1
BPA (TTM)
$-1.11
Ingresos (TTM)
$2M
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$1 – $8
CYCN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2M
2019-12-31
→
2025-12-31
BPA
$-1.11
2021-12-31
→
2025-12-31
Flujo de caja libre
—
2019-12-31
→
2022-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CYCN
Mediana de Pares
P/E (TTM)
-1.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CYCN
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CYCN
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CYCN
Mediana de Pares
Revenue YoY (Ingresos interanuales)
3.7%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
91.1%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
-2.0%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CYCN
Mediana de Pares
CYCN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
1 analistas · 2026-08-17
Mín
$8.00
Máx
$8.00
Objetivo mediano
$8.00
+94,2%
Objetivo medio
$8.00
+94,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.37%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de diciembre de 2025 | $-0.21 | $-0.39 | 0.18% |
| 30 de septiembre de 2025 | $-0.30 | — | — |
| 30 de junio de 2025 | $-0.11 | — | — |
| 30 de septiembre de 2023 | $-0.93 | $-0.34 | -0.59% |
| 30 de septiembre de 2022 | $-4.80 | $-6.32 | 1.5% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CYCN | — | -1.1 | 3.7% | — | — | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| TPST | $14M | -0.5 | — | — | -319.3% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| R&D Expense | $959.0K | $286.0K | $2M | $6M | $38M | $56M | $95M | |
| SG&A Expense | $6M | $5M | $8M | $13M | $21M | $29M | $34M | |
| Operating Expenses | $7M | $6M | $13M | $19M | $59M | $84M | $130M | |
| Operating Income | $-5M | $-4M | $-13M | $-19M | $-55M | $-81M | $-125M | |
| Other Non-op | $1M | $571.0K | $358.0K | $294.0K | $-16.0K | $588.0K | · | |
| Pretax Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-122M | $-122M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| EPS (Basic) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| EPS (Diluted) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| Shares (Basic) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| Shares (Diluted) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| EBITDA | · | $-4M | $-13M | $-44M | $-55M | · | $-125M |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $8M | $13M | $54M | $54M | $95M | |
| Receivables | $1M | $556.0K | $0 | $96.0K | $100.0K | $0 | · | |
| Prepaid Expense | $384.0K | $421.0K | $442.0K | $805.0K | $928.0K | $816.0K | $2M | |
| Other Current Assets | $11.0K | $16.0K | $11.0K | $537.0K | $468.0K | $3M | $3M | |
| Current Assets | $5M | $4M | $8M | $15M | $55M | $59M | $101M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $65.0K | $7M | $12M | |
| PP&E (Gross) | · | $126.0K | $126.0K | $2M | $2M | $17M | $33M | |
| Accum. Depreciation | · | $126.0K | $126.0K | $2M | $2M | $10M | $22M | |
| Other Non-current Assets | · | · | $0 | $2M | $2M | $3M | $540.0K | |
| Total Assets | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Accounts Payable | $508.0K | $390.0K | $1M | $3M | $2M | $1M | $3M | |
| Short-term Debt | · | · | · | $4M | $4M | $4M | · | |
| Current Liabilities | $900.0K | $725.0K | $2M | $8M | $11M | $17M | $18M | |
| Capital Leases | · | · | · | · | $0 | $39M | $70M | |
| Total Debt | · | · | · | $4M | $4M | · | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Retained Earnings | $-271M | $-267M | $-264M | $-259M | $-215M | $-163M | $-86M | |
| AOCI | · | $0 | $-12.0K | $-20.0K | $-23.0K | $-27.0K | $-20.0K | |
| Stockholders' Equity | $9M | $9M | $11M | $10M | $48M | $59M | $98M | |
| Liabilities + Equity | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Shares Outstanding | 3,821,236 | 2,545,922 | 2,474,159 | 2,175,936 | 2,170,509 | 34,047,300 | 27,598,133 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $65.0K | $472.0K | $2M | $3M | |
| Stock-based Comp | $441.0K | $625.0K | $1M | $6M | $10M | $15M | $20M | |
| Restructuring | · | · | $-565.0K | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-21M | $-41M | $-37M | $-72M | $-102M | |
| CapEx | · | · | · | $0 | $7.0K | $2M | $7M | |
| Investing Cash Flow | · | $0 | $10M | $0 | $1M | $18.0K | $-7M | |
| Stock Issued | $1M | $0 | $5M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $5M | · | · | · | · | |
| Financing Cash Flow | $3M | $0 | $5M | $29.0K | $31M | $28M | $212M | |
| Net Change in Cash | $8.0K | $-4M | $-6M | $-41M | $-4M | $-44M | $103M | |
| Free Cash Flow | · | · | · | $-41M | $-37M | · | $-109M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| Net Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2729.3% | |
| Pretax Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2715.9% | |
| EBITDA Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| ROA | · | · | -33.5% | -113.9% | -59.1% | · | -126.9% | |
| ROE | · | · | -43.6% | -326.8% | -98.7% | · | -113.4% | |
| ROIC | · | · | -114.7% | -318.0% | -106.7% | · | -127.9% |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 3.8 | 1.9 | 5.0 | · | 5.5 | |
| Quick Ratio | · | · | 3.6 | 1.8 | 4.9 | · | 5.2 | |
| Debt / Equity | · | · | · | 0.3 | 0.1 | · | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | 0.0 | 16.6 | 78.8 | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | · | · | -92.5% | 71.7% | · | · | |
| Revenue CAGR 3Y | 91.1% | -20.2% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| Net Income TTM | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| Market Cap | · | · | $8M | $571M | $1.49B | · | $1.50B | |
| Enterprise Value | · | · | · | $561M | $1.44B | · | · | |
| P/E | -1.1 | -2.7 | -1.5 | -0.6 | -26.1 | · | · | |
| P/S | · | · | · | 1922.4 | 378.8 | · | 333.1 | |
| P/B | · | · | 0.7 | 54.6 | 31.0 | · | 15.4 | |
| P / Tangible Book | 0.5 | 0.9 | 0.7 | 54.6 | 31.0 | 35.0 | · | |
| P / Cash Flow | · | · | -0.4 | -14.1 | -40.9 | · | -14.7 | |
| P / FCF | · | · | · | -14.1 | -40.9 | · | -13.8 | |
| EV / EBITDA | · | · | · | -12.6 | -26.1 | · | · | |
| EV / FCF | · | · | · | -13.8 | -39.5 | · | · | |
| EV / Revenue | · | · | · | 1889.2 | 366.0 | · | · | |
| Earnings Yield | -87.4% | -37.6% | -67.2% | -154.6% | -3.8% | · | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $875.0K | $93.0K | $81.0K | $2M | $194.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-720.0K | $0 | |
| R&D Expense | $0 | $730.0K | $519.0K | $348.0K | $56.0K | $36.0K | $56.0K | $81.0K | $105.0K | $44.0K | $24.0K | $580.0K | $339.0K | $572.0K | $-15M | $1M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | |
| Operating Expenses | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $6M | $2M | $3M | $-13M | $5M | |
| Operating Income | $-2M | $-3M | $-838.0K | $-1M | $-2M | $-1M | $502.0K | $-1M | $-1M | $-2M | $-2M | $-6M | $-2M | $-3M | $12M | $-5M | |
| Other Non-op | $16.0K | $32.0K | $39.0K | $30.0K | $1M | $28.0K | $28.0K | $405.0K | $62.0K | $76.0K | $101.0K | $107.0K | $62.0K | $88.0K | $132.0K | $111.0K | |
| Net Income | $-2M | $-3M | $-799.0K | $-976.0K | $-324.0K | $-1M | $530.0K | $-723.0K | $-1M | $-2M | $-2M | $8M | $-4M | $-7M | $-7M | $-10M | |
| EPS (Basic) | $-0.41 | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $-0.32 | $3.10 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | |
| EPS (Diluted) | $-0.41 | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $0.06 | $2.72 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | |
| Shares (Basic) | 4,251,000 | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,555,000 | 2,435,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | |
| Shares (Diluted) | 4,251,000 | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,906,000 | 2,786,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | |
| EBITDA | $-2M | $-3M | · | $-1M | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-6M | $-4M | $-7M | · | $-11M |
Balance general 18
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $3M | $3M | $5M | $3M | $4M | $3M | $3M | $5M | $6M | $8M | $9M | $6M | $7M | $13M | $20M | |
| Receivables | $0 | $0 | $1M | $100.0K | $525.0K | $581.0K | $556.0K | $44.0K | · | · | $0 | $0 | $0 | $96.0K | $96.0K | $227.0K | |
| Prepaid Expense | $112.0K | $255.0K | $384.0K | $386.0K | $462.0K | $256.0K | $421.0K | $621.0K | $116.0K | $308.0K | $442.0K | $726.0K | $1M | $567.0K | $805.0K | $536.0K | |
| Other Current Assets | $11.0K | $11.0K | $11.0K | $11.0K | $27.0K | $21.0K | $16.0K | $11.0K | $11.0K | $10.0K | $11.0K | $30.0K | $428.0K | $503.0K | $537.0K | $488.0K | |
| Current Assets | $2M | $3M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $8M | $10M | $7M | $8M | $15M | $22M | |
| PP&E (Net) | $66.0K | $66.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| PP&E (Gross) | · | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | · | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | |
| Total Assets | $7M | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | |
| Accounts Payable | $2M | $457.0K | $508.0K | $480.0K | $462.0K | $483.0K | $390.0K | $304.0K | $651.0K | $741.0K | $1M | $814.0K | $2M | $4M | $3M | $2M | |
| Current Liabilities | $2M | $2M | $900.0K | $877.0K | $800.0K | $1M | $725.0K | $700.0K | $1M | $1M | $2M | $2M | $5M | $8M | $8M | $9M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-276M | $-274M | $-271M | $-270M | $-269M | $-269M | $-267M | $-268M | $-267M | $-266M | $-264M | $-263M | $-270M | $-266M | $-259M | $-252M | |
| AOCI | · | · | · | · | · | · | · | $0 | $0 | $-16.0K | $-12.0K | $-18.0K | $-16.0K | $-19.0K | $-20.0K | $-28.0K | |
| Stockholders' Equity | $5M | $7M | $9M | $10M | $9M | $9M | $9M | $8M | $9M | $10M | $11M | $13M | $5M | $4M | $10M | $17M | |
| Liabilities + Equity | $7M | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | |
| Shares Outstanding | 4,256,284 | 4,241,260 | 3,821,236 | 3,695,158 | 3,075,968 | 3,060,944 | 2,545,922 | 2,530,898 | 2,515,874 | 2,499,601 | 2,474,159 | 2,445,096 | 2,407,796 | 43,524,894 | 2,175,936 | 43,494,184 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Stock-based Comp | $51.0K | $58.0K | $95.0K | $118.0K | $114.0K | $114.0K | $122.0K | $138.0K | $184.0K | $181.0K | $103.0K | $159.0K | $379.0K | $426.0K | $1M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $-692.0K | $-127.0K | $0 | · | · | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-264.0K | $-503.0K | $-968.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $-7M | $-7M | $-6M | $-7M | $-10M | |
| CapEx | $0 | $66.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $0 | $-66.0K | · | · | $0 | $0 | · | $0 | · | · | $0 | $10M | · | · | $0 | $0 | |
| Stock Issued | · | · | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $825.0K | $251.0K | $2M | $-130.0K | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $12.0K | $0 | |
| Net Change in Cash | $-1M | $-417.0K | $-1M | $2M | $-633.0K | $407.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $3M | $-2M | $-6M | $-7M | $-10M | |
| Free Cash Flow | · | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | -111.5% | -348.4% | -1764.2% | · | -372.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | |
| ROA | -21.5% | -34.6% | · | -10.1% | -3.3% | -13.5% | · | -6.0% | -13.1% | -13.5% | · | 37.6% | -18.5% | -24.0% | · | -22.6% | |
| ROE | -25.7% | -40.8% | · | -11.0% | -3.7% | -15.3% | · | -6.9% | -19.0% | -22.3% | · | 51.5% | -27.4% | -34.0% | · | -28.8% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.8 | · | 5.8 | 5.0 | 4.2 | · | 5.1 | 3.7 | 4.2 | · | 4.2 | 1.4 | 1.1 | · | 2.5 | |
| Quick Ratio | 0.8 | 1.6 | · | 5.3 | 4.4 | 4.0 | · | 4.2 | 3.6 | 4.0 | · | 3.9 | 1.1 | 1.0 | · | 2.4 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 0.0 | · | 12.2 | 0.4 | 0.2 | · | 8.8 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $368.0K | $275.0K | · | $194.0K | $0 | $0 | · | $0 | $306.0K | $1M | · | $1M | |
| Net Income TTM | $-6M | $-6M | · | $-3M | $-4M | $-5M | · | $4M | $521.0K | $-5M | · | $-14M | $-35M | $-44M | · | $-48M | |
| Market Cap | $14M | $7M | · | $8M | $9M | $8M | · | $7M | $6M | $8M | · | $8M | $10M | $378M | · | $748M | |
| P/E | -2.1 | -0.9 | · | -1.8 | -2.0 | -1.2 | · | 2.0 | -8.8 | -1.1 | · | -0.5 | -0.3 | -0.6 | · | -1.5 | |
| P/S | 13.8 | 6.3 | · | 6.8 | 24.3 | 27.8 | · | 33.8 | · | · | · | · | 32.4 | 371.5 | · | 548.1 | |
| P/B | 2.8 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | |
| P / Tangible Book | 2.8 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | |
| P / Cash Flow | · | -5.6 | · | · | · | -7.9 | · | · | · | -4.3 | · | · | · | -60.8 | · | · | |
| P / FCF | · | -5.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -46.6% | -111.6% | · | -54.8% | -51.2% | -80.0% | · | 49.4% | -11.3% | -91.6% | · | -208.8% | -388.8% | -166.9% | · | -67.2% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $2M | $2M | $0 | $297.0K | $4M |
| Margen Operativo % | — | -181.4% | — | -2730.6% | -1400.2% |
| Beneficio neto | $-4M | $-3M | $-5M | $-44M | $-52M |
| EPS Diluido | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | — | — | — | 0.3 | 0.1 |
| Ratio corriente | — | — | 3.8 | 1.9 | 5.0 |
| Ratio Rápido | — | — | 3.6 | 1.8 | 4.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | — | — | $-41M | $-37M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 24 declarantes · $10.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 11 (+6 vs trimestre anterior) | 5 (0 vs trimestre anterior) | 3 (+2 vs trimestre anterior) | 2 (0 vs trimestre anterior) | +2.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Kalehua Capital Management LLC | $5 598 077 | 1 651 350 | 52,72% | Acciones |
| FMR LLC | $1 226 457 | 361 787 | 11,55% | Acciones |
| Balyasny Asset Management L.P. | $1 076 362 | 317 511 | 10,14% | Acciones |
| ADAR1 Capital Management, LLC | $1 012 786 | 298 757 | 9,54% | Acciones |
| BRAIDWELL LP | $531 857 | 156 890 | 5,01% | Acciones |
| TYNDALL CAPITAL PARTNERS L P | $451 594 | 155 187 | 4,25% | Acciones |
| CITADEL ADVISORS LLC | $202 705 | 59 795 | 1,91% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $150 759 | 44 460 | 1,42% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $104 802 | 30 915 | 0,99% | Acciones |
| Rangeley Capital, LLC | $82 411 | 24 310 | 0,78% | Acciones |
| BlackRock, Inc. | $56 942 | 16 797 | 0,54% | Acciones |
| TWO SIGMA ADVISERS, LP | $35 941 | 28 300 | 0,34% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $31 680 | 9 345 | 0,30% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $24 927 | 7 353 | 0,23% | Acciones |
| VANGUARD GROUP INC | $20 494 | 16 137 | 0,19% | Acciones |
| Tower Research Capital LLC (TRC) | $6 268 | 1 849 | 0,06% | Acciones |
| UBS Group AG | $1 939 | 572 | 0,02% | Acciones |
| GROUP ONE TRADING LLC | $651 | 192 | 0,01% | Acciones |
| OSAIC HOLDINGS, INC. | $440 | 130 | 0,00% | Acciones |
| Activest Wealth Management | $339 | 100 | 0,00% | Acciones |
| BARCLAYS PLC | $295 | 87 | 0,00% | Acciones |
| WHI TRUST Co LLC | $244 | 72 | 0,00% | Acciones |
| HRT FINANCIAL LP | $74 | 22 054 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $14 | 4 | 0,00% | Acciones |
Informantes de la empresa 21 insiders · 7 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Regina Margaret Graul | President and Chief Executive Officer | 14 de agosto de 2026 M | 107 523 | 0 | 0 | $0 |
| Rhonda M. Chicko | Chief Financial Officer | 14 de agosto de 2026 M | 25 018 | 0 | 0 | $0 |
| Anjeza Gjino | Chief Financial Officer | 20 de enero de 2022 A | 31 599 | 0 | 0 | $0 |
| Mark G Currie | President and CSO | 28 de diciembre de 2020 S | 251 648 | 0 | 0 | $0 |
| Cheryl Gault | Chief Operating Officer | 20 de enero de 2022 A | — | 0 | 0 | $0 |
| Andreas Busch | Chief Scientific Officer | 20 de enero de 2022 A | 254 704 | 0 | 0 | $0 |
| Christopher I Wright | Chief Medical Officer | 25 de febrero de 2021 S | 42 728 | 0 | 0 | $0 |
| Peter M. Hecht | Consejero | 16 de julio de 2026 C | 910 240 | 0 | 0 | $0 |
| Michael J Higgins | Consejero | 25 de marzo de 2025 A | 30 740 | 0 | 0 | $0 |
| Steven Hyman | Consejero | 30 de noviembre de 2023 A | 20 000 | 0 | 0 | $0 |
| Errol B Desouza | Consejero | 30 de noviembre de 2023 A | 30 000 | 0 | 0 | $0 |
| Terrance McGuire | Consejero | 30 de noviembre de 2023 A | 5 552 | 0 | 0 | $0 |
| Stephanie Lovell | Consejero | 14 de junio de 2022 A | 2 421 | 0 | 0 | $0 |
| Ole Isacson | Consejero | 14 de junio de 2022 A | 2 421 | 0 | 0 | $0 |
| Michael Mendelsohn | Consejero | 14 de junio de 2022 A | 2 421 | 0 | 0 | $0 |
| Marsha Fanucci | Consejero | 14 de junio de 2022 A | 16 950 | 0 | 0 | $0 |
| George N Conrades | Consejero | 14 de junio de 2022 A | 4 334 | 0 | 0 | $0 |
| Kevin Churchwell | Consejero | 24 de junio de 2021 A | 2 421 | 0 | 0 | $0 |
| Amy Schulman | Consejero | 16 de junio de 2020 A | 21 635 | 0 | 0 | $0 |
| IRONWOOD PHARMACEUTICALS INC | Propietario del 10% | 1 de abril de 2019 J | 0 | 0 | 0 | $0 |
| William Huyett | — | 6 de noviembre de 2020 S | 67 590 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Peter M. Hecht ×9 presentaciones | 20 de julio de 2026 | 19,40% | Enmienda | — | SEC |
| SLATE PATH MASTER FUND LP, SLATE PATH CAPITAL LP, JADES GP, LLC, DAVID GREENSPAN | 21 de octubre de 2022 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.